Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about aplp1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Gene Symbol | APLP1 |
| Full Name | Amyloid Beta Precursor-Like Protein 1 |
| Chromosome | 19q13.3 |
| Function | is a type I transmembrane glycoprotein expressed predominantly in the nervous system, where it participates in diverse cellular processes including synapse development, plasticity, and network exci... |
| Primary Expression | the central nervous system with particularly high levels in the hippocampus (especially CA1 pyramidal neurons and dentate gyrus granule cells), cerebr |
| Amino Acids | 770 aa |
| UniProt ID | [Q15804](https://www.uniprot.org/uniprot/Q15804) |
| Ensembl ID | ENSG00000105248 |
| GeneCards | APLP1 |
| Human Protein Atlas | APLP1 |
| Associated Diseases | Alzheimer's disease |
| Interactions | AMYLOID, APOE, CLDN5, LAG3, MMP9, PARKINSON |
| KG Connections | 23 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
aplp1["aplp1"]
LAG3(["LAG3"])
aplp1 -->|"interacts_with"| LAG3
SYNUCLEIN["SYNUCLEIN"]
aplp1 -->|"interacts_with"| SYNUCLEIN
__SYNUCLEIN["alpha-SYNUCLEIN"]
aplp1 -->|"interacts_with"| __SYNUCLEIN
AMYLOID(["AMYLOID"])
aplp1 -->|"interacts_with"| AMYLOID
NEURONS["NEURONS"]
aplp1 -->|"activates"| NEURONS
Neurodegeneration{"Neurodegeneration"}
Neurodegeneration -->|"activates"| aplp1
APOE(["APOE"])
APOE -->|"interacts_with"| aplp1
style aplp1 fill:#1a3a4a,stroke:#ce93d8,stroke-width:3px,color:#ce93d8| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:APLP1 | data_in | dataset_row | 0.00 |
| Alpha-Synuclein Transmission | associated_with | process | 0.95 |
| LAG3 | interacts_with | protein | 0.95 |
| Synaptic Plasticity | regulates | process | 0.90 |
| Alpha-Synuclein | associated_with | protein | 0.85 |
| Dopaminergic Neurodegeneration | contributes_to | phenotype | 0.85 |
| Alzheimer's Disease | correlates_with | disease | 0.85 |
| Als | protects_against | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Cancer | contributes_to | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Vascular Dementia | interacts_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Dementia | interacts_with | disease | 0.65 |
| Alzheimer | contributes_to | disease | 0.65 |
| Inflammation | interacts_with | disease | 0.65 |
| Vascular Dementia | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| AND | activates | gene | 0.60 |
| AMYLOID | interacts_with | gene | 0.60 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| Amyloid | interacts_with | pathway | 0.60 |
| Dopaminergic | activates | cell_type | 0.60 |
| Neuron | activates | cell_type | 0.60 |
| DEMENTIA | therapeutic_target | gene | 0.60 |
| Oxidative Stress | therapeutic_target | pathway | 0.60 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.60 |
| Endothelial | therapeutic_target | cell_type | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| MMP9 | interacts_with | gene | 0.60 |
| IL-17 | therapeutic_target | gene | 0.60 |
| Amyloid | therapeutic_target | protein | 0.60 |
| Il-1 | therapeutic_target | protein | 0.60 |
| App | therapeutic_target | protein | 0.60 |
| AKT | activates | gene | 0.60 |
| APP | protects_against | gene | 0.60 |
| ADAM10 | activates | gene | 0.60 |
| NPAS4 | regulates | gene | 0.60 |
| APP | regulates | gene | 0.60 |
| SOD1 | interacts_with | gene | 0.60 |
| APOE | interacts_with | gene | 0.60 |
| CLDN5 | interacts_with | gene | 0.60 |
| Α-Synuclein | therapeutic_target | protein | 0.60 |
| MTHFR | interacts_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:APLP1 | data_in | dataset_row | 0.00 |
| VPS35 | regulates | protein | 0.90 |
| APP | interacts_with | protein | 0.85 |
| GALANGIN | binds_to | compound | 0.80 |
| CLDN5 | interacts_with | gene | 0.60 |
| MMP9 | interacts_with | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| curcumin | targets | drug | 0.60 |
| resveratrol | targets | drug | 0.60 |
| AMYLOID | interacts_with | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| DEMENTIA | therapeutic_target | gene | 0.60 |
| APP | associated_with | gene | 0.60 |
| APLP2 | associated_with | gene | 0.60 |
| APLP2 | regulates | gene | 0.60 |
| APOE | interacts_with | gene | 0.60 |
| SOD1 | interacts_with | gene | 0.60 |
| APLP2 | protects_against | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| TNF | interacts_with | gene | 0.60 |
| LAG3 | interacts_with | gene | 0.60 |
| AGING | activates | gene | 0.60 |
| ALZHEIMER | contributes_to | gene | 0.60 |
| AMYLOID | associated_with | gene | 0.60 |
| CANCER | contributes_to | gene | 0.60 |
| ALZHEIMER'S DISEASE | contributes_to | gene | 0.60 |
| AMYLOID | therapeutic_target | gene | 0.60 |
| IL-17 | therapeutic_target | gene | 0.60 |
| DEMENTIA | interacts_with | gene | 0.60 |
| INFLAMMATION | interacts_with | gene | 0.60 |
| NATURAL COMPOUNDS | interacts_with | gene | 0.60 |
| OXIDATIVE STRESS | interacts_with | gene | 0.60 |
| IL-17 | interacts_with | gene | 0.60 |
| AND | interacts_with | gene | 0.60 |
| APOE | interacts_with | gene | 0.50 |
| Neurodegeneration | activates | disease | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning aplp1 in their description or question text
No additional research found